LEGAL GUIDES FOR CONSUMERS ON DANGEROUS DRUGS

If you suffered from Elmiron side effects, call a Nashville Elmiron lawyer, you may be eligible for a Elmiron lawsuit

The Firm is reviewing claims on behalf of Interstitial Cystitis (IC) patients who took the prescription drug Elmiron and now may be suffering from a severe eye disease called maculopathy or has suffered vision impairment as a result.  If you developed malculopathy or a vision impairment and took Elmiron, or have additional questions, give Nashville Elmiron Lawyer Timothy L. Miles a call today for a free case evaluation, you could be entitled to significantly compensation if you meet the Elmiron Lawsuit Criteria and file an Elmiron lawsuit.

Read on for answer to four frequently asked questions about an Elmiron lawsuit and see if you are eligible for an Elmiron lawsuit.

Since 1996, millions of patients have been prescribed Elmiron in order to treat their interstitial cystitis (IC), otherwise known as painful bladder syndrome. But there is now reason to believe that this drug may cause a serious eye condition in those taking it, one that may result in blindness.

This condition is a form of maculopathy – the degeneration of the macula, the central part of the retina. Maculopathy’s first symptoms are blurred vision, dark spots, trouble focusing, and other impairments: as it progresses, it may lead to total blindness.
​
As the evidence has piled up, the manufacturer of Elmiron – Janssen Pharmaceuticals – has failed to warn the public about these risks. Millions of people are taking a drug that may one day rob them of their vision, and an untold number may have already suffered serious health conditions.

Elmiron eye damage lawsuits on behalf of the injured have already begun claiming their maculopathy was caused by Elmiron.  If you or a loved one took Elmiron and has since been diagnosed with maculopathy, or vision impairment or other serious Elmiron side effects, you may be eligible for compensation. Contact a Nashville Elmiron Lawyer today to have your case reviewed for free and see if you meet the Elmiron lawsuit criteria.​

​​​In 2018, researchers at the Emory Eye Center at the Emory School of Medicine in Atlanta alerted the public that taking Elmiron is linked to the retinal condition, maculopathy.  Pentosan polysulfate sodium can cause severe vision problems and side effects, including interstitial cytitis, and even blindness.

Nieraj Jain, M.D., of Emory Eye Center in Atlanta, Ga., reported that six Elmiron patients who had been taking Elmiron for about 15 years had developed unusual changes in their macula.

Because nothing in the patients’ medical history or diagnostic tests explained the subtle, but striking pattern of abnormalities, Dr. Jain and his colleagues raised a warning flag that long-term use of Elmiron may damage the retina.

The retina is a thin layer of tissue that lines the back of the eye on the inside. It is located near the optic nerve. The retina receives light that the lens has focused and converts the light into neural signals. It then sends these signals on to the brain for visual recognition

All patients in the study reportedly showed signs of retinal disease and that the youngest patient in the study was diagnosed with interstitial cystitis at 23 years of age. That patient began taking the medication daily and began showing visual symptoms by the age of 30. In addition, three ophthalmologists conducted a review of patients at Kaiser Permanente in Northern California and found that approximately one-quarter of patients with significant exposure to Elmiron showed definite signs of eye damage. 

It also found the medication could potentially be linked to retinal conditions, such as age-related macular degeneration or pattern dystrophy. Patients who have used or are using the pentosan polysulfate sodium drug Elmiron are advised to be screened by ophthalmologists if they are experiencing any unusual eye symptoms.  They are also advised to cease pentosan therapy if eye disease is present.

​​A newly discovered condition has come to light, and it is presently unknown how many symptoms there actually are, or how serious this can end up being for those suffering from it.
The currently known symptoms associated with this eye condition include:

• A change in the color of the retina itself
• Dark spots in visions 
• Straight lines turned curved or squiggly
• Muted, less vivid colors
• Trouble reading
• Blurred vision, including in the center of the field of view
• A hard time adjusting to dimmer lighting 
• Blindness

You may be eligible for an Elmiron lawsuit if meet the following criteria:

•        Elmiron patients need to have used the prescription medication for at least a year.
•        And are now suffering from vision impairment

​​
The criteria are based upon the medical studies linking the drug to eye disease and vision impairment, including interstitial cytitis and maculopathy.  However, there may be exceptions to the Elmiron lawsuit criteria.  There may be other eye damage claims available for you to pursue and you still may be eligible for an Elmiron lawsuit. ​​

If you were diagnosed with maculopathy or vision impairment caused by Elmiron, or other serious Elmiron Side Effects, contact a Nashville Elmiron Lawyer today as you most likely meet the Elmiron lawsuit criteria and are eligible for an Elmiron lawsuit and possibly recover substantial compensation.  The call is free and so is the fee unless we will you case.  So, call today and see what a Nashville Elmiron lawyer can do for you. 

So, give a Nashville Elmiron Lawyer call today or submit the free case evaluation form if you suffered Elmiron Side Effects and see if you and are eligible to file an Elmiron lawsuit. ​

If you suffered Onglyza Side Effects contact Nashville Onglyza lawyer Timothy L. Miles, you could be eligible for an Onglyza lawsuit

Onglyza (saxagliptin) and Kombiglyze XR (saxagliptin and metformin) belong to a new class of diabetic drugs known as DPP-4 inhibitors. Onglyza gained federal drug approval by the U.S. Food & Drug Administration (FDA) despite initial concerns over the cardiovascular safety of the drug.

These concerns were echoed in a post-marketing safety study that found Onglyza may be associated with an increased risk of heart failure and an increased risk of death.

If you or a loved one took Onglyza as directed and suffered from Onglyza side effects including heart failure or other cardiovascular injuries—such as congestive heart failure or myocardial infarction, after starting Onglyza therapy, contact Nashville Onglyza lawyer Timothy L. Miles today for a free case evaluation to see if you are eligible for an Onglyza lawsuit and possibly entitled to substantial compensation.  

​​Onglyza (saxagliptin) is an add-on medication to diet and exercise to improve blood sugar control in people with type 2 diabetes.  It is a is a dipeptidyl peptidase-4 (DPP-4) inhibitor that increases the amount of insulin your body makes. Onglyza comes in tablets in dosages of 2.5 mg and 5 mg taken once by mouth daily.

​​You should not take Onglyza if you are allergic to any of its ingredients. Serious allergic reactions can occur with Onglyza including swelling of the face, throat, lips and difficulty breathing, among others. Your doctor should test your blood to measure how well your kidneys work before and during treatment with Onglyza. You may need a lower dose of Onglyza if your kidneys are not working well.

​​​Type 2 diabetes patients have a significantly increased risk of cardiovascular complications, and the majority of diabetics die from such complications. Amid growing concerns over the safety of many diabetes drugs, in 2008 the FDA recommended that the makers of new type 2 diabetes drugs provide evidence that the drugs do not increase the risk of cardiovascular events such as heart attacks. 

Onglyza met the FDA's cardiovascular safety criteria. Though the FDA approved the new diabetic drug, it had reservations about the sufficiency of Onglyza clinical trials and ordered AstraZeneca to perform a post-marketing study. As a result, AstraZeneca completed a 16,000-patient cardiovascular outcomes trial called SAVOR. The results of that trial were published in the New England Journal of Medicine and raised major Onglyza safety concerns.

​SAVOR found that Onglyza patients were 27% more likely to be hospitalized for heart failure. The study also found a significant increase in the rate of “all-cause mortality” among Onglyza patients.
The warning signs of heart failure include:

• Shortness of breath
• Persistent cough or wheezing
• Swelling in the lower extremities or abdomen
• Fatigue
• Nausea
• Diminished appetite
• Impaired cognitive ability
• Increased heart rate

Following the release of SAVOR, the FDA issued an Onglyza drug safety communication and convened an advisory committee meeting to analyze the results and recommend further action. The committee voted 14-to-1 to add information to Onglyza’s label warning about heart failure risks. The other member voted to withdraw Onglyza from the U.S. market.

The committee, however, did not advise updating the warning label to address the measured increase in all-cause mortality among Onglyza patients and did not recommend any restrictions on prescribing the drug.

In an April 2016 drug safety communication, the FDA announced that Onglyza and Kombiglyze XR are now required to carry warnings about heart failure risk. Other FDA warnings about saxagliptin include:

• A warning about severe joint pain
• A warning about pancreatitis and pancreatic cancer

​​In addition to heart failure, Onglyza is linked to these adverse Onglyza side effects:

• Severe joint pain
• Pancreatitis
• Pancreatic cancer
• Thyroid cancer
• Severe allergic reactions
• Hypoglycemia
• Upper respiratory tract infection
• Urinary tract infection

​​If you or a loved one took Onglyza as directed and suffered suffered heart failure, death, or another serious cardiovascular injury, after starting Onglyza therapy, you may meet the requirements for an Onglyza lawsuit and possibly be entitled to substantial compensation. Call a Nashville​ Onglyza lawyer for free today who can tell you if you are eligible for an Onglyza lawsuit.

If you meet the requirements for an Onglyza lawsuit and are successful you can recover money for some of the following damages:
     • Past and future medical bills (including medication, hospital stays, and in-home care)
     • Pain and suffering
     • Lost wages
     • Loss of earning capacity
     • Funeral expenses (in the event of a loved one’s death)
 
Broadly speaking, a plaintiff who is eligible for an Onglyza lawsuit could be entitled to compensation for any past and future costs associated with their diagnosis if they meet the requirements for an Onglyza lawsuit and are successful. ​

​It does not cost anything to hire a Nashville Onglyza lawyer.  We take all cases on a contingency basis which means we do not get paid unless we win your case.  A Nashville Onglyza lawyer can explain the process and answer any questions you may have including whether you are eligible for an Onglyza lawsuit.  Call a Nashville Onglyza lawyer today for a free case evaluation.

If you or a loved one took Onglyza as directed and suffered from Onglyza Side Effects, specifically: heart failure, death or another serious cardiovascular injury —such as congestive heart failure or myocardial infarction, after starting Onglyza therapy, contact Nashville​ Onglyza lawyer Timothy L. Miles today to see if you are eligible for a Onglyza lawsuit and possibly entitled to substantial compensation. ​​

If you suffered Valsartan side effects, contact Nashville Valsartan lawyer Timothy L. Miles today

Patients who have taken Valsartan and have been diagnosed with cancer, as a result, should read on to learn more about how they can hold the drug makers accountable.

Valsartan has been recalled due to possible nitrosamine contamination. Nitrosamines can cause tumors in the liver and other organs in lab animals and are thought to be carcinogenic in humans as well. It is believed that these blood pressure drugs were tainted during flawed manufacturing processes. The U.S. Food and Drug Administration (FDA) stated that these contaminants “are of special concern to global regulators because, unlike most impurities in drugs, they have the potential to cause harm at very low levels.”

The recalls began in July when the FDA found that some Valsartan products contained a potentially cancer-causing chemical. European regulators had already made the same discovery. The substance can form during manufacturing if the chemical reactions used to make the drug are not carefully controlled and monitored, the FDA said.

Valsartan is made by Chinese manufacturer Zhejiang Huahai Pharmaceuticals. These recalls are a product of greater FDA scrutiny of foreign drug imports, but FDA warnings alone will not ensure safe medications. In a culture where the profit motive exists, drug companies must be held accountable to cutting corners and sacrificing consumer safety. 

​If you or a loved one took Valsartan and later were diagnosed with cancer or other serious Valsartan Side Effects, contact Nashville Valsartan lawyer Timothy L. Miles today for a free case evaluation to see if you are eligible for a Valsartan lawsuit and possibly entitled to substantial compensation. ​

Read on for the answers to five frequently asked questions about a Valsartan lawsuit by a Nashville Valsartan lawyer. 

​In July 2018, the FDA announced the Valsartan Recall due to contamination. The recall was prompted because of the discovery of a cancer-causing agent in the drug. The FDA launched an investigation into the cause and impact of the contamination which led to several additional recalls over the following year.  The FDA also found that other blood pressure drugs contained impurities.  

The first recall was prompted by the finding of the impurity N-nitrosodimethylamine (NDMA). Later, the FDA later discovered the second impurity, N-Nitrosodiethylamine (NDEA).   While neither compound has been studied in humans, both have been shown to cause cancer in animal studies.  ​

​​​In addition to cancer, sources say other Valsartan Side Effects include:

• kidney failure,
• liver failure,
• a lowered white blood cell count, and
• angioedema, the swelling of certain tissues in the body.

This medication has been associated with birth defects and should not be taken by pregnant women for this reason. (Consult your physician for more information.). If you or a loved one took Valsartan and later were diagnosed with Valsartan side effects, call Nashville Valsartan Lawyer Timothy L. Miles today for a free case evaluation to see if you are eligible for a Valsartan Lawsuit.

​​​If you took Valsartan and subsequently were diagnosed with cancer, or experienced other serious Valsartan side effects, then you may be eligible for a Valsartan lawsuit possibly may be entitled to substantial compensation. Contact Nashville Valsartan Lawyer Timothy L. Miles today and see if are eligible for a Valsartan lawsuit.